✦ LIBER ✦

Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC?

✍ Scribed by Zheng, Yulong; Xu, Nong; Zhou, Jianying

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intercalated chemotherapy and erlotinib:

✍ Mok, Tony S K; Wu, Yi-Long 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 48 KB

Chemotherapy for patients with advanced

✍ William K. Oh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A phase II study of Gemcitabine (G) plus

✍ Ventriglia, M; Estevez, R; Cabrera, L; Spector, C; Álvarez, A.A; Cilurzo, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Intercalated combination of chemotherapy

✍ Wu, Yi-Long; Lee, Jin Soo; Thongprasert, Sumitra; Yu, Chong-Jen; Zhang, Li; Ladr 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 586 KB

First-line erlotinib in patients with ad

✍ Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Ger 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 314 KB

MO19390 (SAiL): Bleeding events in a pha

✍ Dansin, Eric; Cinieri, Saverio; Garrido, Pilar; Griesinger, Frank; Isla, Dolores 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB